Dr Andrea Marie Eberle, OD | |
10998 Omalley Centre Dr, Ste D, Anchorage, AK 99515-3069 | |
(907) 344-3700 | |
(907) 344-3717 |
Full Name | Dr Andrea Marie Eberle |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 17 Years |
Location | 10998 Omalley Centre Dr, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376742452 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 260 (Alaska) | Primary |
Provider Name | Eberle Eyecare P.c. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1285952549 PECOS PAC ID: 3577740414 Enrollment ID: O20110602000191 |
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrea Marie Eberle, OD 10998 Omalley Centre Dr, Ste D, Anchorage, AK 99515-3069 Ph: (907) 344-3700 | Dr Andrea Marie Eberle, OD 10998 Omalley Centre Dr, Ste D, Anchorage, AK 99515-3069 Ph: (907) 344-3700 |
News Archive
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
› Verified 9 days ago
Dr. Gary Michael Kjome, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515 Phone: 907-349-6932 Fax: 907-349-6347 | |
Marko J Hrgovic, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Debarr Rd, Anchorage, AK 99508 Phone: 907-269-9542 Fax: 907-269-9541 | |
Dr. Patrick Reber, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1345 W 9th Ave, Anchorage, AK 99501 Phone: 907-272-2557 Fax: 907-274-4932 | |
Makar Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4411 Business Park Blvd, Bldg. M Ste 10, Anchorage, AK 99503 Phone: 907-770-6652 Fax: 907-770-3668 | |
North Star Optical, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5710 Denali St, Anchorage, AK 99518 Phone: 907-444-8854 Fax: 888-612-1315 | |
Victoria Ann Blower, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 101, Anchorage, AK 99503 Phone: 907-272-9800 Fax: 907-277-1398 | |
Dimond Vision Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 1000 E Dimond Blvd Ste 101, Anchorage, AK 99515 Phone: 907-349-6932 Fax: 907-349-6347 |